期刊文献+

大剂量N-乙酰半胱氨酸对染尘大鼠肺组织的影响 被引量:4

Effects of high-dose N-acetylcysteine on the lung tissues of rats exposed to silica
原文传递
导出
摘要 目的 观察大剂量N-乙酰半胱氨酸(NAC)对矽肺形成过程中炎症和纤维化反应的影响.方法 将Wisar大鼠随机分为模型组、干预组、对照组,每组32只.模型组和干预组以二氧化硅结晶体诱发染尘大鼠模型,干预组以大剂量NAC进行干预.分别在染尘后的第3、7、14、28天处死8只大鼠.对大鼠肺组织进行HE染色及Masson染色,观察肺组织病理变化.用酶联免疫法(EusA)测定肺泡灌洗液中肿瘤坏死因子-α(TNF-α)和白细胞介素-8(IL-8)的含量.结果 NAC干预组病理观察显示,肺泡炎症和纤维化程度均较模型组明显减轻.与模型组(13.84±1.61、9.23±0.87、11.23±1.25、9.56±0.76)比较,第3、7、14、28天十预组肺脏系数(9.30±0.78、6.29±0.74、7.63±0.88、6.06±1.16)均明显降低.差异有统计学意义(P<0.01.与对照组相比,各时间点模型组肺泡灌洗液中TNF-α和IL-8含量均明显升高,差异有统计学意义(P<0.01);与模型组相比,各时间点干预组的TNF-α和IL-8含量均明显降低,差异有统计学意义(P<0.01).结论 早期大剂量NAC干预能够明显减轻染尘大鼠的肺组织炎症,降低肺泡灌洗液中TNF-α和IL-8含量,抑制和延缓肺纤维化的发生. Objective To explore the effects of high-dose N-acetylcysteine on the lung tissues of rats exposed to silica. Methods Ninety-six Wistar rats were randomly divided into model group, intervention group and control group (32 rats for each group). The rats of model group and intervention group were exposed to silica by intratracheal infusion of silica dust suspension. The rats in the intervention group were orally given high dose N-acetylcysteine. In 3,7,14,28 days after exposure, eight rats in each group were sacrificed, respectively and the lung samples were collected. The pathological changes of lung were evaluated by HE and Masson staining methods. The levels of TNF-α and IL-8 in the BALF were detected by ELISA. Results Compared with the control group, the alveolitis and pulmonary fibrosis in the intervention group were significantly reduced. In 3,7,14,28 days after exposure, the lung/body coefficients in the intervention group were 9.30±0.78, 6.29±0.74,7.63±0.88,6.06+1.16 respectively, which were significantly lower than those (13.84±1.61,9.23±0.87, 11.23±1.25,9.56±0.76, P〈0.01 )in the model group (P〈0.01). At the different time points, the levels of TNF-α and IL-8 in the BALF in the intervention group were significantly higher than those in the control group (P〈0.01), but were significantly lower than those in the model group (P〈0.01). Conclusion The intervention with high dose N-acetylcysteine can significantly reduce the alveolitis and the TNF-α and IL-8 levels in the BALF, therefore, inhibit and delay the development of pulmonary fibrosis of rats exposed to silicon dioxide.
作者 张华 张春玲
出处 《中华劳动卫生职业病杂志》 CAS CSCD 北大核心 2011年第7期510-513,共4页 Chinese Journal of Industrial Hygiene and Occupational Diseases
关键词 矽肺 乙酰半胱氨酸 肿瘤坏死因子 病理学 Silicosis Acetylcysteine Tumor necrosis factor Pathology
  • 相关文献

参考文献10

  • 1Cortijo J, Cerda-Nicolas M, Serrano A, et al. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J, 2001, 17:1228-1235.
  • 2Yildirim Z, Kotuk M, Iraz M, et al. Attenuation of bleomycin-in- dueed lung fibrosis by oral sulfhydryl containing antioxidants in rats:erdosteine and N-acetylcysteine. Pulm Pharmacol Ther, 2005, 18:367-373.
  • 3Teixeira KC, Soares FS, Rocha LG, et al. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcys- teine plus deferoxamine. Pulm Pharmacol Ther, 2008, 21:309-316.
  • 4Mata M, Rufz A, Cerda M, et al. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Resoir J, 2003, 22:900-905.
  • 5杜海科,王世鑫,刘彦,张诗武.烟酸对染矽尘大鼠一氧化氮合酶表达的影响[J].中华预防医学杂志,2004,38(3):186-189. 被引量:10
  • 6de Souza PM, Lindsay MA. Apoptosis as a therapeutic target for the treatment oflunz disease Curr Ooin Pharmacol. 2005. 5:232-237.
  • 7Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant theraov. Resoir Med. 1998. 92:609-623.
  • 8Rahman Q, Abidi P, Afaq F,t al.Glutathione redox system in oxidative lung injury. Crit Rev Toxicol, 1999, 29:543-568.
  • 9Gon Y, HashimotoS, Nakayama T,et al.N-acetyl-L-cysteine inhibits bleomycin-induced interleukin-8 secretion by bronchial epithelial ceils. Respirology, 2000, 5:309-313.
  • 10MacNee W. Oxidants/antioxidants and chronic obstructive pulmonary disease:pathogenesis to therapy. Novartis Found Syrup, 2001, 234: 169-185.

二级参考文献17

  • 1闻芝梅 陈君石(译).现代营养学[M].北京:人民卫生出版社,1998..
  • 2Hunninghake GW,Kalica AR. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med,1995,151:915-918.
  • 3Giri SN, Gurujeyalakshmi G, Wang Y. Suppression of bleomycin-induced increased production of nitric oxide and NF-kB activation by treatment with taurine and niacin. Adv Exp Med Biol, 2000,483:545-561.
  • 4Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J, 2001,357:593-615.
  • 5Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med, 1998,157:1666-1680.
  • 6Nathan C, Xie QW. Nitric oxide synthase: roles, tolls, and controls. Cell,1994,78:915-918.
  • 7Chen F, Sun SC, Kuh DC,et al. Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun, 1995,214:985-992.
  • 8Hanada T,Yoshimura A.Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev,2002,13:413-421.
  • 9Ogata S, Takeuchi M, Teradaira S, et al. Radical scavenging activities of niacin-related compounds. Biosci Biotechnol Biochem, 2002, 66: 641-645.
  • 10Pieper AA, Verma A, Zhang J, et al. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci,1999,20:171-181.

共引文献9

同被引文献41

  • 1何玉先,刘秉慈,缪庆,王海华,尤宝荣.汉防己甲素抑制矽肺胶原mRNA表达的研究[J].中华预防医学杂志,1995,29(1):18-20. 被引量:22
  • 2刘秉慈,何玉先,缪庆,尤宝荣,王海华.汉防己甲素及克矽平对矽肺大鼠Ⅰ型和Ⅲ型胶原mRNA的影响[J].生物化学杂志,1995,11(1):100-103. 被引量:7
  • 3张智健.N-乙酰半胱氨酸在呼吸系统疾病中的应用[J].中国药物应用与监测,2007,4(2):20-22. 被引量:28
  • 4Cho BS, Kim SD, Park JK, et al. Effects of Bupleurum falcatum and its combination with an angiotension II receptor blocker on cytokine and chemkine expression in human messangial cell. Phytother Res, 2010, 24: 339-343.
  • 5Carvajal G, Rodriguez-Vital J, Rodrigues-Diez R, et al. Angiotensin II activates the Smad pathway during epithelial mcscnchymal transdifferentiation. Kidney Int, 2008, 74: 585-595.
  • 6Boffa JJ, Lu Y, Plaeier S, et al. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol, 2003, 14:1132-1144.
  • 7Papp M,Li X, Zhuang J, et al. Angiotension receptor subtype AT(I) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol, 2002, 282:713-718.
  • 8Marshall RP,McAnuhy R J, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med, 2000, 161: 1999-2004.
  • 9Li x, Molina-Molina M, Abdul-Hafez A, et al. Extravaseular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am J physiol lung cell Mol Physiol, 2006, 291:1.887-895.
  • 10Marshall RP, Gohlke P, Chambers RC, et al. Angiltensin II and the fibroproliferative response to acute lung injury. Am J Physiol lung cell Mol Physiol, 2004, 286:L156-164.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部